# A Study Evaluating the Safety and Efficacy of Cura-100 in Subjects With Rheumatoid Arthritis and Osteoarthritis

> **NCT00455208** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Cura Biotech LLC** · enrollment: 20 (estimated)

## Conditions studied

- Rheumatoid Arthritis
- Osteoarthritis

## Interventions

- **DRUG:** Cura-100

## Key facts

- **NCT ID:** NCT00455208
- **Lead sponsor:** Cura Biotech LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-05
- **Primary completion:** —
- **Final completion:** 2008-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2009-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00455208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00455208, "A Study Evaluating the Safety and Efficacy of Cura-100 in Subjects With Rheumatoid Arthritis and Osteoarthritis". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00455208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*